Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun;10(2):204-16.
doi: 10.1007/s11481-015-9603-3. Epub 2015 Apr 16.

Effects of Cannabinoids on T-cell Function and Resistance to Infection

Toby K Eisenstein  1 , Joseph J Meissler
Affiliations
Review

Effects of Cannabinoids on T-cell Function and Resistance to Infection

Toby K Eisenstein et al. J Neuroimmune Pharmacol. 2015 Jun.

Abstract

This review examines the effects of cannabinoids on immune function, with a focus on effects on T-cells, as well as on resistance to infection. The paper considers the immune modulating capacity of marijuana, of ∆(9)-THC extracted from the marijuana plant, and synthetic cannabinoids. Of particular interest are synthetic compounds that are CB2 receptor (CB2R) selective agonists. As the CB2R is principally expressed on cells of the immune system, agonists that target this receptor, and not CB1 (which is mainly expressed on neurons), have the possibility of altering immune function without psychoactive effects. The overall conclusion of the studies discussed in this review is that cannabinoids that bind to the CB2 receptor, including ∆(9)-THC and CB2 selective agonists are immunosuppressive. The studies provide objective evidence for potentially beneficial effects of marijuana and ∆(9)-THC on the immune system in conditions where it is desirable to dampen immune responses. Evidence is also reviewed supporting the conclusion that these same compounds can sensitize to some infections through their immunosuppressive activities, but not to others. An emerging area of investigation that is reviewed is evidence to support the conclusion that CB2 selective agonists are a new class of immunosuppressive and anti-inflammatory compounds that may have exceptional beneficial effects in a variety of conditions, such as autoimmune diseases and graft rejection, where it is desirable to dampen the immune response without psychoactive effects.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The author declares that she has no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Akhmetshina A, Dees C, Busch N, Beer J, Sarter K, Zwerina J, Zimmer A, Distler O, Schett G, Distler JH. The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis. Arthritis & Rheum. 2009;60:1129–1136. - PubMed
    1. Baczynsky WO, Zimmerman AM. Effects of Δ9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system of mice. I. in vivo investigation of the primary and secondary immune response. Pharmacology. 1983;26:1–11. - PubMed
    1. Basu S, Dittel BN. Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease. Immunol Res. 2011;51:26–38. - PMC - PubMed
    1. Börner C, Höllt V, Kraus J. Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription. Neuroimmunemodulation. 2007;14:281–286. - PubMed
    1. Börner C, Smida M, Hollt V, Schraven B, Kraus J. Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling. J Biol Chem. 2009;284:35450–35460. - PMC - PubMed

Publication types

MeSH terms